Immunoglobulins against viral proteins, including EA-IgG, VCA-IgA, and Rta-IgG, may be used as molecular biomarkers for predicting the prognosis of nasopharyngeal cancer. This evidence concerns the gene CD79A and nasopharyngeal carcinoma.